Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type

Transplantation

Volumn 73, Issue 5, 2002, Pages 745-751

  Olofsson, Bert Ove ^a   Backman, Christer ^a   Karp, Kjell ^a   Suhr, Ole B ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN;

ADULT; AMYLOID NEUROPATHY; AMYLOIDOSIS; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; DISEASE COURSE; ECHOCARDIOGRAPHY; FAMILIAL DISEASE; FEMALE; FOLLOW UP; GENE MUTATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; LIVER TRANSPLANTATION; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0037087692     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200203150-00015     Document Type: Article

References (38)

1. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy
2. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy
3. Amyloidosis
4. New structural information and update on liver transplantation in transthyretin-associated amyloidosis. Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders and the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umea, Sweden, June 1999
5. Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser
6. A peculiar form of peripheral neuropathy: Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves
7. Familial amyloidotic polyneuropathy in Japanese
8. Familial amyloidosis with polyneuropathy: A clinical study based on patients living in northern Sweden
9. Worldwide survey of liver transplantation in patients with familial amyloidotic polyneuropathy
10. Transthyretin amyloidosis
11. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)
12. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
13. Liver transplantation for hereditary transthyretin amyloidosis
14. Liver transplantation as a treatment for familial amyloidotic polyneuropathy
15. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation
16. Outcome of liver transplantation for transthyretin amyloidosis: Follow-up of Japanese familial amyloidotic polyneuropathy patients
17. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
18. Liver transplantation in familial amyloidotic polyneuropathy: Follow-up of the first 20 Swedish patients
19. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: Regression of visceral amyloid following liver transplantation
20. Liver transplantation restores endocrine cells in patients with familial amyloidotic polyneuropathy
21. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation
22. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: Ocular synthesis of mutant transthyretin
23. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis
24. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant
25. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis
26. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
27. Myocardial texture characterization by two-dimensional echocardiography
28. Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy
29. Familial amyloidotic polyneuropathy in northern Sweden: A cross-sectional and longitudinal study of cardiac function with echocardiography
30. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy
31. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin
32. Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30 Met)
33. Hypertropic cardiomyopathy associated with tacrolimus in pediatric transplant patients
34. Immunosuppressive drugs and hypertrophic cardiomyopathy
35. Tacrolimus and cardiotoxicity in adult liver transplant recipients
36. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression
37. Fibril in senile systemic amyloidosis is derived from normal transthyretin
38. Familial amyloidosis with polyneuropathy: A long-term follow-up of 21 patients with special reference to gastrointestinal symptoms